文献检索

查找使用阿拉丁产品的科研文献

检索与阿拉丁产品相关的同行评审论文、DOI、PubMed 编号、期刊、作者、CAS 号及研究领域。

科研影响力快照

与阿拉丁产品相关的已发表科研成果

在搜索之前,这些指标可帮助访客快速了解产品关联科研的规模与质量。

347,550+ SCI 论文 与阿拉丁产品引用相关
2,304,480.59 总影响因子 匹配文献记录中影响因子的总和
81.20 最高期刊影响因子 匹配期刊中的最高 IF
6.63 平均期刊影响因子 匹配文献的平均 IF

参考指标 指标基于阿拉丁文献引用数据库及期刊影响因子记录。文献关联仅供科研参考,请以原始文献为准。

产品列表

视图 列表 网格

显示第3997至4008个,产品总数347,550个

切换升序
Advanced Science · 2026 · IF 14.1

Graphene‐Engineered Rear Interfaces Enable Efficient Flexible CZTSSe Solar Cells on Metal Foils

Yixiong Ji,Wentong Yang,Di Yan,Wei Luo,Jialu Li,Shi Tang,Jintao Fu,James Bullock,Mei Gao,Xin Li,Zhancheng Li,Jun Yang,Zhenghong Xiong,Yang Peng,Pengjun Zhao,Xingzhan Wei,Haofei Shi,Paul Mulvaney,Fangyang Liu

Flexible kesterite Cu 2 ZnSn (S,Se) (CZTSSe) solar cells on metal foils are attractive for lightweight and conformable photovoltaic applications, yet their efficiencies remain significantly lower than those of rigid devices due to severe foil‐induced rear‐interface losses during high‐temperature chalcogenization. These effects include uncontrolled Mo(S,Se) formation, interfacial instability, and the emergence of blocking back‐contact barriers that hinder efficient carrier extraction. Here, we introduce a single‐crystal graphene interlayer to engineer the Mo foil/CZTSSe interface. The atomically thin graphene layer decouples absorber growth from the mechanically and chemically non‐ideal foil surface, suppressing detrimental interfacial reactions and stabilizing the rear interface. As a result, carrier extraction is enhanced, and the back‐contact barrier is reduced toward quasi‐ohmic behavior. Flexible CZTSSe solar cells with graphene‐engineered interfaces achieve a champion efficiency of 11.6% with simultaneous improvements in V OC , J SC , and fill factor. These results highlight rear‐interface stabilization as a key strategy for improving flexible kesterite photovoltaics on metal substrates. An atomically thin graphene interlayer stabilizes the rear interface of flexible CZTSSe solar cells by regulating interfacial stress, suppressing detrimental interfacial reactions, and reducing the back‐contact barrier. This strategy simultaneously improves photovoltaic performance and mechanical durability.

✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
Journal of Manufacturing and Materials Processing · 2026 ·Vol. 10 ·期 7 ·255 · IF 4

Laser Remelting-Induced Microstructure Refinement and Strengthening of (TaWZrHf)95Y5 Refractory High-Entropy Alloy

Chuanbing Huang,Junnan Jin,Yonghui Sun,Hao Lan,Weigang Zhang

A novel (TaWZrHf)95Y5refractory high-entropy alloy (RHEA) matrix was fabricated via vacuum hot pressing (VHP) sintering and subsequently modified through laser remelting (LR) surface treatment. Thermodynamic phase diagram calculations predicted the alloy’s dual-phase BCC structure, and the effects of LR on phase composition, microstructure, and mechanical properties were systematically investigated. LR induced a significant phase transition, promoting rapid solidification and substantial grain refinement. The surface hardness increased to 848 HV0.2, approximately 1.5 times higher than that of the matrix, while the compressive strength reached 1635 MPa, surpassing the matrix by 200 MPa without compromising ductility. Importantly, the LR process effectively mitigated rare-earth (yttrium) segregation and loss, a common challenge in conventional arc melting of refractory HEAs, thereby enhancing solid solution strengthening and phase stability. This work pioneers the application of laser surface engineering to VHP-sintered refractory HEAs, bridging critical gaps in fabrication, microstructural optimization, and performance enhancement, and offering valuable insights for the future design of high-performance multi-principal element alloy development.

✓ 已验证 DOI 高影响因子
查看原文 查看 PubMed
NATURE BIOTECHNOLOGY · 2026 · IF 44.5

High-throughput synthesis of DNA fragments by molecular self-assembly of overlapping oligonucleotides

Wu Zhiguang,Sun Zhengyang,Jiang Shuangying,Wang Yaqi,Bai Tanxi,Zeng Cheng,Cai Zelin,Su Chenghao,Zhang Xiandi,Chen Yunan,Shen Yue,Zhu Chenyou,Xiang Ye,Fang Fang,Xia Ninuo,Liu Dongsheng,Dai Junbiao,Wei Bryan

The limitations of DNA synthesis technologies are a fundamental bottleneck in synthetic biology. Here we present a high-throughput gene synthesis method driven by hybridization, called Molecular Self-Assembly Induced Cloning. Molecular Self-Assembly Induced Cloning overcomes molecular crosstalk and oligo misalignment across genes by coupling orthogonal self-assembly of overlapping DNA segments in vitro with the DNA repair machineries of host cells in vivo. Cellular uptake of the assembled target fragments serves as templates for recovery and cloning. We adopt microchip-based oligonucleotide synthesis, enabling the production of over 1,000 distinct gene fragments in a simple one-pot reaction. Near-zero misalignment is an indispensable feature of the parallel synthesis, with oligo synthesis errors remaining at a constant but controllable level. We also construct massive variant libraries of the industrial enzyme PETase and discover higher-potency variants than the gold standard enzyme.

CAS / MDL: 7262-40-0
✓ 已验证 产品关联 DOI 高影响因子
查看原文 查看 PubMed
CHEMICAL ENGINEERING JOURNAL · 2026 · IF 12.5

A phase-matched flexible PVDF ultrasonic transducer for efficiently powering implantable bioelectronics

Jinlong Sun,Boling Lan,Shenglong Wang,Hongguang Li,Tianpei Xu,Longchao Huang,Peiwen Li,Wei Zhao,Yong Ao,Long Jin,Wei Zhu,Weiqing Yang,Weili Deng

A phase-matched double-layer flexible PVDF ultrasonic transducer is proposed for ultrasonic energy harvesting. • Tunable PDMS spacing enables in-phase piezoelectric output superposition and enhanced acoustic-to-electric conversion. • The device delivers 156.56 μW output power with an 89.12% enhancement and achieves about 2.2 V after rectification and filtering. Securing a continuous and biocompatible power supply remains a primary challenge for implantable devices. Ultrasonic wireless power transfer based on poly(vinylidene fluoride) (PVDF) transducers exhibits excellent acoustic impedance matching with soft tissues. However, insufficient acoustic-to-electric conversion efficiency restricts their practical applications. Here, we propose a vertically stacked ultrasonic energy harvester integrating dual PVDF functional layers. Guided by theoretical acoustic wavelength calculations and multiphysics simulations, the interlayer spacing is rationally engineered to achieve identical phase responses across both functional layers during ultrasonic propagation. This phase-matched architecture enables synchronized acoustic excitation and constructive superposition of piezoelectric potentials across the stacked PVDF layers, thereby maximizing acoustic energy conversion. Evaluated under a weak ultrasonic field, the device delivers an output power of 156.56 μW and a power density of 423.14 μW/cm 3 , demonstrating an 89.12% improvement over conventional single-layer devices without compromising intrinsic structural flexibility. Meanwhile, compared with conventional piezoelectric ceramic transducers, the proposed PVDF-based device retains the distinctive advantages of low acoustic impedance, full flexibility, and improved tissue conformability, which are highly desirable for efficient ultrasonic coupling and energy transfer in implantable applications. This phase-matching strategy provides a scalable approach to improve the efficiency of polymer-based piezoelectric harvesters, advancing the development of sustainable power sources for implantable bioelectronics.

CAS / MDL: 70131-67-8
✓ 已验证 产品关联 DOI 高影响因子
查看原文 查看 PubMed
BIORESOURCE TECHNOLOGY · 2026 · IF 8.2

Synthetic microalgal–bacterial symbiotic system integrating oxidase-protease fusion enzyme for simultaneous removal of recalcitrant nitrogen-containing organic compounds and PET microplastics

Rui Xiao,Yushu Li,Peng Liu,Howard H. Chou

Oxidase–protease fusion enzyme (A20674) removes recalcitrant nitrogenous compounds. • PETase-evolved strain B84 shows 3 × higher IAA and 4 × PET removal. • Synthetic symbiosis enables 9 × microplastic and 5 × plastic fragment removal. • Optimized microalgal-bacterial consortium reduced organic nitrogen to ≤ 5 mg/L. • Performance validated in industrial and defined wastewaters. Industrial wastewaters—particularly those from the printing and dyeing sector—contain complex mixtures of recalcitrant nitrogen-containing organic compounds and microplastics that resist conventional treatment. Here we report a previously undescribed oxidase–protease fusion enzyme (A20674), discovered through transcriptomic analysis of wastewater-acclimated Chlorella vulgaris . Domain dissection reveals that the oxidase-like region drives broad-spectrum removal of N -heterocyclic and aromatic compounds, while the protease-like domain removes organic nitrogen. Engineered overexpression of this enzyme boosted organic nitrogen removal up to fifty-five-fold (final concentration 13–100 mg/L) across different industrial wastewaters. Capitalizing on this metabolic specialization, we constructed a synthetic microalgal–bacterial consortium in which Pseudomonas putida uses microalgal extracellular polysaccharides (EPS) as a carbon source to sustain growth, while supplying indole-3-acetic acid that stimulates microalgal biomass and EPS production. Reciprocal engineering of EPS overproduction in C. vulgaris and enhanced polysaccharide-catabolism in P. putida amplified this mutualistic loop. An evolved, PETase/MHETase-expressing P. putida strain simultaneously acquired elevated IAA output, further strengthening the symbiosis. The optimized consortium reduced organic nitrogen concentrations by sixteen-fold to discharge-compliant levels (≤5 mg/L), enhanced removal of recalcitrant organic nitrogen compounds by five-fold (final concentration 34 mg/L), and improved PET microplastic removal by nine-fold (initial concentration 1 g/L and final concentration 684 mg/L) in printing and dyeing wastewater. These findings uncover a bifunctional enzyme architecture for degrading structurally diverse industrial pollutants, and establish a synthetic-ecology framework for integrated removal of dissolved nitrogen-containing organic compounds and particulate microplastics—a combination unattainable by any single organism or conventional treatment process.

✓ 已验证 DOI 高影响因子
查看原文 查看 PubMed
PHYTOMEDICINE · 2026 · IF 11.3

Targeting the PLEC/TPM4 cytoskeletal axis: DT-13 inhibits colorectal cancer metastasis through direct binding to PLEC and inactivation of Akt/ERK signaling

Jing-Yu Feng,Jing-Ling Yang,Rui Zhang,Kiran Thakur,Jian-Guo Zhang,Jianbo Xiao,Zhao-Jun Wei

DT-13 potently inhibits CRC metastasis with a favorable biosafety profile. • Plectin (PLEC) is identified as the direct intracellular binding target of DT-13. • DT-13 occupies the PLEC CH domain to physically disrupt the PLEC-TPM4 interactome. • Target engagement down-regulate TPM4 and suppresses Akt/ERK-driven EMT programs. Background Metastasis is the leading cause of colorectal cancer (CRC) mortality. Standard 5-fluorouracil (5-FU) has limited anti-metastatic efficacy and dose-dependent toxicities, underscoring the need for therapeutic alternatives with improved safety profiles. Methods This study investigated the anti‑metastatic mechanism of Liriope muscari baily saponins C (DT‑13) in CRC. Cell viability, migration, and invasion were assessed in HCT116 cells. An orthotopic CRC model was established in BALB/c nude mice to compare the therapeutic efficacy and hematological safety of DT-13 against 5-FU. Direct targets of DT-13 were identified using chemical proteomics (small‑molecule pull‑down, cellular thermal shift assay, drug affinity responsive target stability assay) and molecular dynamics simulations. Results DT-13 inhibited HCT116 proliferation (IC 50 ∼19 μM) and reduced migration and invasion by 78% and 90% in vitro. In vivo , DT-13 achieved a comparable reduction in tumor volume to 5-FU (21% of control volume), while exhibiting a favorable safety profile. Chemical proteomics identified plectin (PLEC) as a primary direct target of DT-13. Molecular docking revealed a binding affinity of –7.654 kcal/mol. Mechanistically, DT-13 occupied the calponin homology domain of PLEC, disrupting its interaction with tropomyosin-4 (TPM4). This led to TPM4 downregulation and subsequently inhibition of Akt and ERK signaling pathways, thereby suppressing the epithelial-mesenchymal transition process. Conclusion DT‑13 exerts anti-metastatic effects in CRC by disrupting the PLEC/TPM4 cytoskeletal scaffold. DT-13 achieved potent anti-metastatic efficacy with a significantly improved systemic safety profile compared to 5-FU. These findings highlight the clinical potential of DT-13 as a safer therapeutic alternative for patients with metastatic CRC. Download: Download high-res image (126KB) Download: Download full-size image

CAS / MDL: 51-21-8
✓ 已验证 产品关联 DOI 高影响因子
查看原文 查看 PubMed
Applied Materials Today · 2026 · IF 7

A ROS-responsive degradable hydrogel integrating MnO2 nanoparticles and gemcitabine for synergistic chemodynamic-chemotherapy of breast cancer

Pingan Li,Xiaodan Chen,Jingyang Su,Qin Zhang,Lin Lin

A ROS-responsive degradable hydrogel is developed for localized breast cancer therapy. • The hydrogel integrates MnO 2 -mediated chemodynamic therapy with gemcitabine chemotherapy. • Tumor microenvironment-triggered ROS generation accelerates hydrogel degradation and drug release. • The self-amplifying therapeutic cascade enhances antitumour efficacy with favourable biosafety. Breast cancer therapy remains limited by systemic side effects, intratumoral drug accumulation and tumor recurrence, highlighting the need for effective localized treatment strategies. Herein, we develop a reactive oxygen species (ROS)-responsive degradable hydrogel for localized chemodynamic-chemotherapeutic breast cancer therapy. Bovine serum albumin-templated MnO 2 (BM) nanoparticles and gemcitabine (Gem) are incorporated into a thiol-norbornene photocrosslinked polyethylene glycol (PEG) network containing ROS-cleavable thioketal (TK) linkers. Such a hydrogel serves not only as a local drug depot, but also a tumor microenvironment-activated therapeutic system. Within this microenvironment, MnO 2 consumes endogenous glutathione (GSH) and reacts with hydrogen peroxide (H 2 O 2 ) to generate Mn 2+ and hydroxyl radicals (·OH), inducing oxidative damage and perturbing tumour redox homeostasis. The resulting ROS further cleave TK linkers, accelerating hydrogel degradation and Gem release. This self-amplifying feedback couples chemodynamic therapy with chemotherapy, enabling localized, stimuli-responsive drug delivery and enhanced antitumour efficacy. In vitro and in vivo evaluations confirm significant tumor suppression and favourable biosafety. These findings highlight a microenvironment-responsive hydrogel platform for regional combination therapy of breast cancer. Download: Download high-res image (207KB) Download: Download full-size image A ROS-responsive degradable hydrogel is designed for localized chemo-chemodynamic breast cancer therapy. BSA-templated MnO 2 nanoparticles and gemcitabine are encapsulated within a thiol-norbornene photocrosslinked PEG hydrogel containing ROS-cleavable thioketal linkers. After implantation at the tumor site, MnO 2 reacts with tumor-overexpressed glutathione and hydrogen peroxide to generate Mn 2+ and hydroxyl radicals, thereby depleting intracellular antioxidants and enhancing chemodynamic therapy. The elevated ROS simultaneously cleave thioketal linkers, triggering hydrogel degradation and accelerating gemcitabine release. This tumor microenvironment-activated cascade integrates ROS-amplified chemodynamic therapy with localized chemotherapy, achieving potent tumor cell killing and improved therapeutic safety.

✓ 已验证 产品关联 DOI 高影响因子
查看原文 查看 PubMed
Cardiovascular Toxicology · 2026 ·Vol. 26 ·期 9 ·98 · IF 3.3

Integrated Multi-omics Reveals CDKN1A Suppression and Metabolic Regulation as Key Mechanisms of Huangqi Guizhi Wuwu Decoction Against Doxorubicin-Induced Cardiotoxicity

Hou Qian,Yu Xinyue,Wu Ke,Chen Siling,Mao Xin,Qian Xinying,Li Changjin,Sheng Lidan,Wang Ruiping,Huang Yin

The clinical utility of doxorubicin (DOX) is severely limited by dose-dependent cardiotoxicity, for which effective interventions remain scarce. Huangqi Guizhi Wuwu Decoction (HGWD) shows promising cardioprotective potential, but its mechanisms against DOX-induced cardiotoxicity (DIC) remain unexplored. This study explored the molecular mechanisms using an integrated metabolomics and transcriptomics approach. We identified 57 compounds in HGWD by liquid chromatography ion trap time-of-flight mass spectrometry (LC-IT-TOF/MS), and quantified five representative compounds for standardization. Mice were randomized into six groups: control, DOX (10 mg/kg × 2), DOX + low-dose HGWD (7 g/kg/d), DOX + high-dose HGWD (14 g/kg/d), DOX + dexrazoxane (100 mg/kg × 2), and HGWD (14 g/kg/d) alone. HGWD effectively alleviated cardiac dysfunction and reduced serum injury markers, with the high-dose group demonstrating efficacy comparable to the positive control drug, dexrazoxane. Subsequently, multi-omics profiling was performed on heart tissues from the control, DOX, and DOX + high-dose HGWD groups. Metabolomics identified 31 differential metabolites, highlighting energy metabolism restoration (e.g., acylcarnitines, citric acid) and inflammatory mediator modulation (e.g., arachidonic acid). Transcriptomics uncovered 37 genes enriched in innate immunity (e.g., Irf7 , Isg15 ) and apoptosis (e.g., Bax , Cdkn1a ). Network analysis constructed a core regulatory module, pinpointing CDKN1A as a potential mediator. Validation experiments confirmed that HGWD suppressed DOX-induced CDKN1A upregulation in mouse hearts. Furthermore, in H9c2 cells, HGWD mitigated DOX-induced apoptosis and inflammation, exhibiting cytoprotection comparable to pifithrin-α, a specific p53 inhibitor. In summary, HGWD protects against DIC by modulating a multi-target network and the suppression of CDKN1A represents a key underlying mechanism. Graphical

CAS / MDL: 24584-09-6 63208-82-2
✓ 已验证 产品关联 DOI 高影响因子
查看原文 查看 PubMed
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY · 2026 · IF 4

A mechanism investigation on the effective strategy for alleviating acute myocardial infarction associated with sleep deprivation

Chen Haiyang,Zhang Lijun,Liu Meiyan,Li Yanwei,Wei Dajian,Wei Jingjing,Li Xiaofeng,He Dongfang,Chi Yunpeng

Acute myocardial infarction (AMI) and insomnia are mutually causal. However, therapeutic strategies for AMI combined with insomnia remain limited. Mechanistically, parachlorophenylalanine (PCPA)-induced sleep deprivation (SD) exacerbates AMI by activating the sympathetic nervous system and triggering systemic inflammatory responses. However, the specific cascade through which PCPA-induced SD-mediated systemic inflammation aggravates myocardial injury remains unclear. Bisoprolol amlodipine tablet (BAT), containing bisoprolol and amlodipine, exerts cardiovascular protective effects, in which bisoprolol mitigates sympathetic overactivation, while amlodipine alleviates AMI-related inflammatory responses. Shumian capsule (SMC) improves sleep quality with potential anti-inflammatory and neuroprotective properties. Given the complementary mechanisms of BAT and SMC, and the unmet clinical need for safe, effective therapies targeting AMI-insomnia comorbidity, this study aims to explore the therapeutic mechanisms of BAT combined with SMC on myocardial injury induced by AMI and PCPA-induced SD, providing novel insights for clinical practice. Male Sprague Dawley rats were randomly divided into five groups: sham, MI, MI + SD, BAT, and BAT + SMC. The MI model was established by ligating the left anterior descending coronary artery, and the SD model was induced by intraperitoneal injection of parachlorophenylalanine. After model establishment, rats in the BAT group received BAT (1.05 mg/kg, i.g.), and those in the BAT + SMC group received BAT combined with SMC (252 mg/kg, i.g.) for one week. Behavioral tests, echocardiography, heart rate, heart weight (HW)/body weight (BW), HW/tibia length (TL), histopathological staining, immunofluorescence co-localization, ELISA, qRT-PCR, and Western blot were used to evaluate anxiety- and depression-like behaviors, cardiac function, tissue injuries, inflammatory responses, and related gene and protein expression. PCPA-induced SD mediated the aggravation of MI-induced anxiety and depression-like behaviors, hippocampal and myocardial pathological injuries, myocardial fibrosis, apoptosis, and cardiac dysfunction in rats. It also increased the levels of myocardial injury biomarkers and inflammatory cytokines, and was accompanied by elevated activation status of the Panx1/P2X7 pathway, which may correlate with promoted neutrophil recruitment and changes in NETosis-related markers. Compared with monotherapy with BAT, the BAT combined with the SMC group showed more favorable alterations across all measured parameters. Compared with monotherapy with BAT, the combination of BAT and SMC showed more favorable alterations in all measured parameters. BAT combined with SMC improved the sucrose preference index and locomotor activity, ameliorated neuronal and dendritic injuries in the hippocampus, increased left ventricular ejection fraction and shortening fraction, reduced left ventricular end-diastolic and end-systolic diameters, HR, HW/BW, and HW/TL, alleviated myocardial fibrosis and apoptosis, decreased the levels of CK-MB, cTnI, TNF-α, and IL-1β, was correlated with suppressed expression of Panx1 and P2X7, and presented lower levels of NETosis-related markers (MPO, NE, and Cit-H3). BAT combined with SMC may alleviate myocardial injuries in rats with AMI and PCPA-induced SD via alterations to the Panx1/P2X7 pathway-associated changes in NETosis-related markers. This combined intervention integrates the cardiovascular-protective actions of BAT with the sleep-improving and neuroprotective properties of SMC, which may help relieve the vicious cycle of PCPA-induced SD-triggered inflammation and myocardial damage. Our findings reveal a molecular link between the Panx1/P2X7-associated changes in NETosis-related markers and the therapeutic benefits of BAT and SMC combination therapy, and provide preclinical evidence for its potential translation into clinical practice. This innovative treatment strategy offers a safe and effective alternative for managing AMI patients with concurrent insomnia, addressing a critical unmet medical need.

CAS / MDL: 7424-00-2
✓ 已验证 产品关联 DOI 高影响因子
查看原文 查看 PubMed
ARCHIVES OF MICROBIOLOGY · 2026 ·Vol. 208 ·期 11 ·583 · IF 3.4

Mechanistic investigation of sucrose monostearate-mediated antifungal effects against Penicillium oxalicum

Sun Yanru,Gao Jing,Jin Xianrui,Li Shuhan,Hou Yexuan,Fu Lu,Zhang Wenhui

Penicillium oxalicum is a major postharvest pathogen of kiwifruit, causing substantial economic losses. This study investigated the antifungal activity and mechanism of sucrose monostearate (SMS) against P. oxalicum . The minimum inhibitory concentration (MIC) of SMS was determined to be 1.25 g L − 1 , which significantly inhibited spore germination by 88.28% and reduced mycelial growth by 65.94% ( p  < 0.05). Mechanistically, SMS at 1.25 g L − 1 induced intracellular ROS accumulation by 1.7-fold, suppressed catalase (CAT) and peroxidase (POD) activities by 54% and 60%, and increased malondialdehyde (MDA) content by 2.5-fold, confirming severe membrane lipid peroxidation and content leakage. Scanning electron microscopy revealed marked hyphal deformation, and in vivo assays showed that SMS reduced kiwifruit lesion diameter by 83.7% compared to controls. These findings demonstrate that SMS, as a single-ester antifungal agent, disrupts fungal membrane integrity and exhibits strong potential for postharvest disease control.

CAS / MDL: 25168-73-4
✓ 已验证 产品关联 DOI 高影响因子
查看原文 查看 PubMed
APOPTOSIS · 2026 ·Vol. 31 ·期 9 ·210 · IF 9

Disrupting KRAS–AGO2 interaction: a dual-pronged strategy to sensitize chemo-immunotherapy in KRAS-mutated colorectal cancer

Xie Jingyi,Wang Simeng,Liu Juan,Zhang Yan,Zhu Haixiao,Cui Rongrong,Yao Yao,Yu Wei,Hou Peng

KRAS mutations are among the most common genetic alterations in colorectal cancer (CRC) and are strongly linked to poor prognosis and therapeutic resistance. However, current treatments targeting KRAS-mutated CRC have shown limited clinical efficacy. Argonaute 2 (AGO2) is a critical component in microRNA (miRNA)-mediated gene silencing complex, which is involved in the maturation of miRNAs and the regulation of target genes. It has been reported that mutated KRAS can interact with AGO2 and impair its function, thereby amplifying the oncogenic potency of mutant KRAS and accelerating tumor progression. To explore the therapeutic implications of this interaction, we developed a peptide inhibitor and engineered peptide-gold nanoparticles (Au-pep) that specifically disrupted KRAS-AGO2 interaction, which dramatically attenuated the malignant phenotype of KRAS-mutated CRC cells. Mechanistically, Au-pep-mediated disruption of the KRAS-AGO2 complex led to partial restoration of the miRNA expression landscape, with let‑7c‑5p emerging as the most significantly up‑regulated effector. As a result, restored let-7c-5p caused a significant down-regulation of key oncogenic drivers (KRAS, c-Myc and Bcl2) to suppress the growth of KRAS-mutated CRC cells and induce their apoptosis. Furthermore, this miRNA restoration conferred dual therapeutic benefits by sensitizing KRAS-mutated CRC cells to 5-fluorouracil (5-FU) via ABCC5 repression and augmenting immunotherapy responsiveness via PD-L1 down-regulation. Our findings, taken together, delineate a new therapeutic paradigm with significant translational potential for improving clinical outcomes in this recalcitrant patient population.

CAS / MDL: 51-21-8
✓ 已验证 产品关联 DOI 高影响因子
查看原文 查看 PubMed
TISSUE & CELL · 2026 · IF 3.1

Effect of Notoginsenoside R1 on reparative dentin formation via regulating the function of human dental pulp stem cells

Xuan He,Dan Liang,Xinyi Zhao,Kaixin Liu,Zicheng Zhang,Meiling Li,Xuemeng Ma,Wenxia Chen,Xiaoyi Zhong

Objective This study investigates the influence of Notoginsenoside R1 (NGR1) on the odontogenic differentiation of human dental pulp stem cells (hDPSCs) and its potential application in direct pulp capping, utilizing both in vitro and in vivo models. The results aim to provide a theoretical basis for expanding the clinical use of NGR1. Methods hDPSCs were isolated, cultured and characterized in vitro. The effects of varying concentrations of NGR1 (0, 50, 100, 200 μg/ml) on cell proliferation and migration were evaluated using the CCK-8 and Transwell assays, respectively. The effect of NGR1 on odontogenic differentiation was evaluated by alkaline phosphatase (ALP) and Alizarin Red S (ARS) staining, as well as RT-PCR to detect the mRNA expression levels of ALP and DSPP. A direct pulp capping model was established in adult dogs. The experimental group was rinsed with 100 μg/ml NGR1 solution before capping, and samples were collected at 1, 4, 8, and 12 weeks. Micro-CT scanning and H&E staining were used to analyze reparative dentin and pulp morphology. Additionally, RNA-Seq of hDPSCs treated with 100 μg/ml NGR1 was conducted, followed by DEG screening, GO/KEGG enrichment, GSEA, and PPI analyses, RT-PCR and IHC were used to verify the DEGs. Results NGR1 promotes hDPSCs proliferation, migration, and odontogenic differentiation. In vitro experiments demonstrated that NGR1 enhanced ALP activity and mineralized nodule formation. Both the 100 μg/ml and 200 μg/ml groups significantly promoted the mineralization of hDPSCs. RT-PCR results showed that mRNA expression levels of ALP and DSPP were significantly upregulated in NGR1-treated groups. Animal experiments revealed the formation of continuous, uniform, and thickened reparative dentin over time in both the Control(0 μg/ml) and NGR1-treated groups. H&E staining showed dentin bridges at 4, 8, and 12 weeks in both Control(0 μg/ml) and NGR1 groups. Histological observations suggested that reparative dentin in the NGR1-treated groups appeared to have numerous, regularly arranged dentinal tubules and a compact architecture, whereas the Control(0 μg/ml) groups showed a relatively less organized structure. RNA-Seq results identified 50 upregulated DEGs, including the dentin-related gene S100A9. These DEGs were enriched in the complement and coagulation cascades, cytokine-cytokine receptor interaction, Staphylococcus aureus infection, and tuberculosis pathways. PPI analysis identified SPRR1A, SPRR1B, and SPRR3 as potential hubs. RT-PCR and IHC confirmed that the expression trends of the differentially expressed genes were consistent with the sequencing results. Conclusion NGR1 promotes the proliferation, migration, and odontogenic differentiation of hDPSCs, with the 100 μg/ml concentration providing an optimal balance between proliferative and pro-differentiation effects. In vivo, NGR1 improves the microstructural quality of reparative dentin. Transcriptomic analysis revealed upregulation of S100A9 and enrichment of repair-related pathways, which may serve as a basis for future mechanistic studies.

✓ 已验证 DOI 高影响因子
查看原文 查看 PubMed
已复制

文献关联基于可获得的产品、CAS、DOI 及引用记录。收录不代表作者或出版方对阿拉丁产品的背书,请以原始文献为准。